Exxon Is Hit With $726 Million Verdict Over Benzene and Cancer
(Bloomberg) -- A jury in Philadelphia found Exxon Mobil Corp. liable for $725.5 million in damages due a former mechanic who claimed its petroleum products exposed him to benzene that caused his cancer, according to his lawyers.
The jury found that the oil company failed to warn Paul Gill of the risk of benzene in its products, including gasoline and solvents, while he worked as a Mobil service station mechanic from 1975 to 1980, his attorneys said in a statement Friday.
Gill's lawyer Patrick Wigle called the verdict “important” and said Exxon has “resisted warning the public and taking basic precautions” to limit exposure to benzene. “We're grateful that this jury listened closely to the testimony and decided it's time to hold corporations like Exxon accountable for placing profits over people,” Wigle said in the statement.
Exxon shares fell as much as 0.7% on Friday, in line with the broad energy sector as oil prices retreated. They were down 0.3% at $118.08 at 3:28 p.m. in New York.
Exxon called the verdict “irrational” and said it would ask the court to reverse it before it becomes final.
“Beyond that request, we plan to exhaust all available appeals and are confident an appellate court will see the verdict for what it is,” the company said in a statement. “We are reviewing our next steps.”
The verdict was reported earlier by Reuters.
The case is Paul Gill and Diane Gill v. ExxonMobil, 200501803, First Judicial District of Pennsylvania.
--With assistance from Kevin Crowley.
More stories like this are available on bloomberg.com
©2024 Bloomberg L.P.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets